MitoSciences

Eugene, United States Founded: 2004 • Age: 22 yrs Acquired By Abcam
Mitochondrial antibodies, assays, and toxicity screening products are provided.

About MitoSciences

MitoSciences is a Healthcare company based in Eugene (United States) founded in 2004, and was acquired by Abcam in May 2011. Mitochondrial antibodies, assays, and toxicity screening products are provided. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Proteomics. Its competitors include GenScript, Epitomics and Vector Laboratories; 2 of its 3 listed competitors have raised funding.

Company details

MitoSciences was established in 2004 in Eugene, United States, within the biotechnology sector focused on mitochondrial research. Monoclonal antibodies and immunoassays are developed to evaluate drug and disease effects on mitochondrial and metabolic functions. Contract research services are offered to support these assessments. Since May 2011, the company has been operated as a subsidiary of Abcam, with activities centered on specialized assays and screening tools.

Key Metrics
  • Latest Funding Round
    $244K (USD), Grant

    Nov 2010

  • Investors
    Abcam

    & 4 more

  • Acquired by
    Abcam

    (May 2011)

Funding Insights of MitoSciences

  • Total Rounds 5
  • Last Round Grant β€” $244,000
  • First Round $591,470

    (Jul 2004)

  • Investors Count 4

All 5 funding rounds of MitoSciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Nov 2010$244,000Grant––
May 2010$590,000Grant––
May 2010$591,470Grant––
Feb 2006$150,000Grant––
Jul 2004$591,470Grant––
Valuation history

5 investors in total: 5 institutional.

Investors in MitoSciences

MitoSciences has secured backing from 5 investors, including institutional investors. Prominent investors backing the company include Abcam, NIH and HHS.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Tax administration and collection services by the US government.
irs.gov
Drug discovery services are provided to the biopharma sector.
1887nih.govUnited States
Provider of event management services
1991oen.orgPortland, United States
Public health and human services are overseen by HHS.
1953hhs.gov
Biological reagents and antibodies are developed for life science research.
1998abcam.comCambridge, United Kingdom
Premium access

Investor details for MitoSciences

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of MitoSciences

4 dated milestones of MitoSciences across 7 years, from founding to its latest funding, stage changes and deals.

  1. Founded MitoSciences is founded.
  2. Funding First funding round of $591K.
  3. Funding Latest funding round, Grant, of $244K.
  4. Exit Acquired by Abcam.

Competitors of MitoSciences

MitoSciences has 3 listed competitors in our database, 2 of them funded. They include GenScript, Epitomics and Vector Laboratories.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
genscript.com2002Piscataway, United States$15M5,260
Reagents and instruments are provided for life sciences research.
epitomics.com2001Burlingame, United States$16.21M
Monoclonal antibody technology and products are developed by Epitomics.
vectorlabs.com1976Burlingame, United States
Labeling and detection reagents immunohistochemistry studies and other life science research applications
Premium access

Detailed competitors of MitoSciences

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of MitoSciences

Websites that share an audience with MitoSciences (mitosciences.com).

Similar websites

Websites whose visitors overlap most with MitoSciences. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
randox-lifesciences.com
100%
View details
abnova.com
100%
30.7K#957,320View details
prospecbio.com
91%
53.2K#651,600View details
epitomics.com
88%
View details
invitrogen.com
88%
5.2K#3,688,642View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 27 similar websites and full traffic analytics for MitoSciences

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 27 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Life Sciences Platforms & Tools

3 companies that operate in the same segment as MitoSciences (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B1,111
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about MitoSciences

MitoSciences was founded in 2004.

MitoSciences is headquartered in Eugene, United States. It is registered at Eugene, Oregon, United States.

MitoSciences was established in 2004 in Eugene, United States, within the biotechnology sector focused on mitochondrial research. Monoclonal antibodies and immunoassays are developed to evaluate drug and disease effects on mitochondrial and metabolic functions. Contract research services are offered to support these assessments. Since May 2011, the company has been operated as a subsidiary of Abcam, with activities centered on specialized assays and screening tools.

MitoSciences's top competitors include GenScript, Epitomics and Vector Laboratories.

MitoSciences has 5 investors. Key investors include Abcam, NIH, HHS, OEN, and Internal Revenue Service.

Yes. MitoSciences was acquired by Abcam in May 2011.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available